During the past decade, G. Kenneth Jansz Medicine Professional Corporation conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "G. Kenneth Jansz Medicine Professional Corporation" #1 sponsor was "CMX Research" with 4 trials, followed by "Bayer" with 2 trials sponsored, "Spectrum Pharmaceuticals, Inc" with 2 trials sponsored, "Acerus Pharmaceuticals Corporation" with 1 trials sponsored and "Ferring Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "G. Kenneth Jansz Medicine Professional Corporation" #1 collaborator was "CMX Research" with 2 trials as a collaborator, "Sanofi" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "G. Kenneth Jansz Medicine Professional Corporation" are "Prostate Cancer" (5 trials), "Bladder Cancer" (2 trials), "Adenocarcinoma of the Prostate" (1 trials), "Cancer" (1 trials) and "Cancer of the Prostate" (1 trials). Many other conditions were trialed in "G. Kenneth Jansz Medicine Professional Corporation" in a lesser frequency.

Most popular intervention types in "G. Kenneth Jansz Medicine Professional Corporation" are "Drug" (8 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Apaziquone" (2 trials), "Darolutamide (Nubeqa, BAY1841788)" (2 trials), "2-Hydroxyflutamide Depot" (1 trials) and "Androgen deprivation therapy (ADT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "G. Kenneth Jansz Medicine Professional Corporation" are 10 trials for "Male" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "G. Kenneth Jansz Medicine Professional Corporation". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in G. Kenneth Jansz Medicine Professional Corporation, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in G. Kenneth Jansz Medicine Professional Corporation, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".